CJC 1295 (NO DAC) + IPA

Buy CJC-1295 No DAC + Ipamorelin
Research Peptide Blend for GH Pulsatility, Regeneration and Metabolic Laboratory Studies
CJC-1295 No DAC + Ipamorelin is an advanced peptide blend studied in preclinical and in vitro research for its combined influence on growth hormone-related signaling pathways. The blend contains CJC-1295 without DAC and Ipamorelin, often abbreviated as IPA.
CJC-1295 No DAC is a synthetic analogue of Growth Hormone-Releasing Hormone — GHRH. Ipamorelin belongs to the class of growth hormone secretagogues and is studied for its interaction with the ghrelin/GHS-R1a receptor. This combination makes the blend relevant for laboratory studies involving GH pulsatility, IGF-1 related pathways, recovery mechanisms, metabolic processes and regenerative research.
Unlike CJC-1295 with DAC, CJC-1295 No DAC has a shorter duration of activity. In research models, this makes it useful for studying a more pulsatile GH signal. The addition of Ipamorelin makes the blend especially relevant for studies where multiple GH-related pathways are investigated simultaneously.
Research Areas of CJC-1295 No DAC + Ipamorelin
GH pulsatility and hormonal signaling pathways
CJC-1295 No DAC + Ipamorelin is studied in models focused on growth hormone release, pulsatile GH activity and related feedback mechanisms.
GHRH and ghrelin receptor research
CJC-1295 No DAC is studied for its interaction with GHRH receptors, while Ipamorelin is investigated in relation to the ghrelin/GHS-R1a receptor.
IGF-1 related pathways
The blend is relevant for studies involving growth hormone and IGF-1 related signaling pathways within preclinical research models.
Muscle, recovery and regeneration research
Researchers use this combination in studies involving protein synthesis, recovery processes, tissue models and regenerative mechanisms.
Metabolism and body composition
CJC-1295 No DAC + Ipamorelin is studied in relation to energy metabolism, fat oxidation, glucose-related pathways and metabolic adaptation.
Skin, collagen and anti-aging research
The blend is relevant for laboratory studies involving collagen formation, skin structure, cellular renewal and age-related processes.
How Does CJC-1295 No DAC + Ipamorelin Work?
CJC-1295 No DAC and Ipamorelin are often combined in laboratory research because they are studied through different but complementary pathways.
CJC-1295 No DAC acts as a GHRH analogue and is investigated for its binding to GHRH receptors. This makes it relevant for studies focused on growth hormone release and pulsatile GH signaling.
Ipamorelin is a growth hormone secretagogue studied for its interaction with the ghrelin/GHS-R1a receptor. In research models, Ipamorelin is often used to analyze the role of ghrelin-related signaling in GH release and metabolic processes.
Together, CJC-1295 No DAC and Ipamorelin form an interesting research blend for studies involving GH pulsatility, IGF-1 pathways, recovery mechanisms, body composition, regeneration and cellular renewal. The activity of this blend is studied exclusively within controlled laboratory and preclinical models.
Preparation and Storage
CJC-1295 No DAC + Ipamorelin is supplied as a lyophilized powder. For laboratory research, the blend may be reconstituted with a suitable solvent according to the applicable research protocol.
Store the product dry, protected from light and refrigerated. Before and after reconstitution, storage between 2°C and 8°C is recommended, unless the batch documentation or internal laboratory protocol states otherwise. Avoid direct sunlight, heat and moisture. Repeated freeze-thaw cycles should be avoided where possible to help preserve peptide blend stability.
Purity and Quality
Each batch of CJC-1295 No DAC + Ipamorelin should be verified for identity and purity through a batch-specific Certificate of Analysis. Depending on the tests performed, the COA may include HPLC analysis, mass spectrometry, purity, peptide content and other relevant quality parameters.
Claims regarding additional contamination testing, such as endotoxins, heavy metals or microbiological contamination, only apply when these are specifically listed on the batch-specific COA.
Legal Disclaimer
CJC-1295 No DAC + Ipamorelin is intended strictly for laboratory research, in vitro research and preclinical use. This product is not intended for human consumption, medical use, diagnostic use, therapeutic treatment or cosmetic application.
All information regarding CJC-1295 No DAC + Ipamorelin is based on laboratory research and preclinical studies. No medical claims are made. Use only within controlled research environments and in accordance with applicable laboratory guidelines.
Learn More
Read our in-depth blog about CJC-1295 No DAC, Ipamorelin and growth hormone-related peptide research for more background information on GH pulsatility, GHRH signaling, ghrelin receptor research and regenerative research models.